» Articles » PMID: 38047935

Predelivery HbA1c Levels and Their Relationship with Adverse Perinatal Outcomes in Women with Normal 75-g OGTT

Overview
Date 2023 Dec 4
PMID 38047935
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To analyze the elevation of HbA1c before full-term delivery in single pregnancy with normal 75 g- Oral glucose tolerance test (OGTT) screening and its association with adverse perinatal outcomes.

Methods: From January to December 2022, an observational prospective study was conducted in a Single centre in China. 365 single pregnant women with normal OGTT were included in the study. HbA1c was measured during OGTT and before full-term delivery, and perinatal outcomes were collected. Participants' pre-delivery HBA1c values were analyzed and perinatal outcomes were compared. Logistic regression analysis was used for independent risk factors associated with elevated pre-delivery HbA1c ≥ 6.0%. The predictive value and truncation value were analyzed by ROC curve.

Results: 15.89% (58/365) of the Participants had a pre-delivery HBA1C value ≥ 6.0%. The incidence of neonatal asphyxia (13.79%, vs. 3.45%, vs. 2.26%, P = 0.007) and amniotic fluid fecal staining (29.31%, vs. 12.64%, vs. 12.03%, P = 0.004) were significantly increased in this group. The independent risk factor associated with pre-delivery HBA1c ≥ 6.0% was the fasting blood glucose(FBG) value of OGTT (OR = 51.308, 95% CI 12.93-203.67, P < 0.01) and the HBA1c value measured during OGTT (OR = 3.608, 95% CI 1.432-9.151, P = 0.007). When FBG was < 4.18 mmol/L and HBA1c was < 5.51%, The accuracy of predicting the pre-delivery HBA1c < 6.0% was 98.2%.

Conclusions: 15.89% of the single pregnancy with normal OGTT had HbA1c ≥ 6.0% before full-term delivery, and they had an increased incidence of neonatal asphyxia and amniotic fluid fecal staining. When the FBG ≥ 4.18 mmol/l or the HBA1c ≥ 5.51% during the OGTT screening, repeated OGTT were recommended in late pregnancy.

References
1.
Kurtzhals L, Norgaard S, Secher A, Nichum V, Ronneby H, Tabor A . The impact of restricted gestational weight gain by dietary intervention on fetal growth in women with gestational diabetes mellitus. Diabetologia. 2018; 61(12):2528-2538. DOI: 10.1007/s00125-018-4736-6. View

2.
Bianco M, Josefson J . Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. Curr Diab Rep. 2019; 19(12):143. PMC: 7008468. DOI: 10.1007/s11892-019-1267-6. View

3.
Plows J, Stanley J, Baker P, Reynolds C, Vickers M . The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018; 19(11). PMC: 6274679. DOI: 10.3390/ijms19113342. View

4.
Fonseca A, Lopes J, Clode N . Glucose intolerance in the third trimester is not predictive of adverse outcomes. Int J Gynaecol Obstet. 2019; 147(1):108-114. DOI: 10.1002/ijgo.12923. View

5.
Sohn J, Lim H, Kim S, Kim T, Kim B, Hwang K . Delayed diagnosis of gestational diabetes mellitus and perinatal outcomes in women with large for gestational age fetuses during the third trimester. Obstet Gynecol Sci. 2020; 63(5):615-622. PMC: 7494771. DOI: 10.5468/ogs.20007. View